1Ronald EL, Goetze S, Xi XP, et al. Expression and function ofP PARγ in rat and human vascular smooth muscle cells[J]. Circulation, 2000, 101: 1311-1318.
2Hupfeld CJ, Weiss RH. TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p^21 and p^27 [J]. Am J Physiol Endocrinol Metab,2001,281 : E207-E216.
3Tao L, Liu HR, Gao E, et al. Rosiglitazone improves endothelial function in rabbits with hypercholesterolemia by reducing oxidative stress and preserving NO/cGMP signaling [J]. Acad Emerg Med, 2003,10:425.
4Gillis T, Mo QZ, Liu HR, et al. Antiapoptotic effects of the PPAR gamma agonist rosiglitazone on aortic endothelial cells in hypercholestemlemic rabbits [J]. Acad Emerg Med, 2003,10: 558.
5Liu FIR, Tao L, Gao E, et al . Pro-inflammatory effects of hypercholesterolemia and anti-inflammatory effects of a peroxisome proliferatoractivated receptor-gamma (PPAR) agonist [J]. Acad Emerg Med 2003,10: 558-559.
6Brenda RK, Samir M, Flore M, et al. PPARγ but not PPARα Li-gands are potent repressors of major histocompatibility complex class Ⅱ induction in atheroma-asaociated cells [J]. Circ Res, 2002, 90: 356-362.
7Nikolaus M, Bettina K, Klaus K, et al. PPAR Activators as antiinflammatory mediators in human T lymphocytes implications for atherosclerosis and transplantation-associated arteriosclerosis[J]. Circ Res, 2002, 90: 703-710.
8Koshiyama H, Shimono D, Kuwamura N, et al. Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes[J] .Clin Endocrinol Metab, 2001,86:3452-3456.
9Andrew CL, Kathleen K. Brown MJ, et al. Peroxisome proliferatoractivated receptor g ligands inhibit development of atherosclerosis in LDL receptor-deficient mice[J].Clin Invest, 2000, 106: 523-531.
10Marx N, Froehlich J, Siam L, et al. Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic padents with coronary artery disease[J]. Arterioscler Thromb Vasc Biol,2003, 23:283-288.
5Zhang Z, Ma JX, Gao G, Li C, Luo L, Zhang M, et al. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization [ J]. Invest Ophthalmol Vis Sc/,2005,46( 11 ) :4062-4071.
7D'Amato RJ,Loughnan MS, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis[J].Proc Nat Acod Sci USA, 1994, 91 (9) :4082-4085.
8Marx N, Schonbeck U, Lazar MA, Libby P, Plutzky J. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells[J]. Circ Res, 1998,83 ( 11 ) : 1097-1103.
9Law RE,Goetze S,Xi XP,Jackson S,Kawano Y,Demer L,et al. Expression and function of PPAR gamma in rat and human vascular smooth muscle cells [ J 1. Circulation,2000,101 ( 11 ) : 1311- 1318.
